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A B S T R A C T
The aim of the paper is to investigate significance of the endoscopic ultrasound (EUS) in diagnostic and staging of
gastric lymphoma. Retrospective clinical study was conducted at the Clinic for Hematology and Clinic for Gastroente-
rology of the University Clinical Center of Sarajevo in the period of years 2002 to 2009. Patients (N=40) with diagnosis
of gastric lymphoma confirmed by pathohistological diagnosis were included in the study. Stage of the disease was deter-
mined based on EUS, proximal endoscopy, CT and ultrasound of abdomen, and classified according to the Ann Arbor
classification. 39 patients had various types of non Hodgkin lymphoma and one patient had Hodgkin lymphoma. Based
on morphological characteristics of gastric tumor visualized with EUS in 16 patients a gastric cancer was suspected. In
40% patients EUS finding was not confirmed by pathohistological finding. Compared both to CT and ultrasound of ab-
domen, EUS showed statistically significant higher frequency of establishing existence of infiltration (p<0.001). In pa-
tients with primary gastric lymphoma EUS has more significant role in determination of stage of disease spread than for
the diagnosis itself. Therefore EUS should be included into algorithm of patient diagnostic protocol when suspected to
the malignant gastric disease.
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Introduction
Primary gastric lymphoma is the most common local-
ization of gastrointestinal lymphoma and it represents
about 70% of all gastrointestinal tract lymphomas1. Fast
development of understanding pathophysiology of all
lymphoma significantly changed approach to this disease
both regarding diagnostic and treatment2. Surgical pro-
cedure, i.e. gastrectomy was one of treatment choices in
the past and the one that was most commonly used.
Lately, due to good results in the treatment of gastric
lymphoma with radiotherapy and chemotherapy, treat-
ment approach is changed and now, gastrectomy is more
often avoided, and non surgical methods are recommen-
ded3,4.
Approach to the gastric lymphoma treatment is to-
tally different from treatment of other types of gastric
malignancies, where primary position in therapy is held
by surgical treatment. In gastric lymphoma, surgical
treatment is completely overrun or is used only in diag-
nostic procedure. It is essential to do endoscopic ultra-
sound (EUS) of stomach to patients with suspicion to
malignant disease of the stomach. Before all, it can estab-
lish suspicion to gastric malignant lymphoma and redi-
rect diagnostic course in that direction. Surgical resec-
tion of the stomach with regional lymph nodes is highly
mutilating method which asks long period of recovery
what prolongs start of the treatment and carries certain
number of late complications. Taken this into account, if
hypothesis is confirmed, the finding of EUS can be used
as sufficiently confident diagnostic and staging of stom-
ach lymphoma spread procedure. Based on this a need
for total gastrectomy can be determined or timely treat-
ment can be started what improves prognosis.
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Use of EUS findings in diagnostic and staging of pri-
mary gastric lymphoma is still controversy. Some au-
thors, based on the results of their investigation, recom-
mend it as a convenient method in the staging process of
lymphoma and as a method which can give convenient
working diagnosis5,6. Certain numbers of papers, which
pose a question about value of EUS finding during diag-
nostic procedure and following treatment outcome, are
also published6.
Considering inconsistent reports, it is questionable in
what extent EUS finding is convenient in establishing
adequate working diagnosis compared to the proximal
endoscopy finding, i.e. its finding which macroscopically
describes gastric mucosa lesion. Via proximal endosco-
pies multiple biopsies of gastric mucosa are sampled for
pathohistological analysis, what gives diagnosis and in
that manner completes diagnostic procedure for gastric
lymphoma7.
There is no consensus on role of the EUS in staging of
the disease and treatment of gastric lymphoma. EUS
finding is very important since it affects choice of ther-
apy and evaluation of its success8. Consensus would
make clinical practice easier and therefore additional in-
vestigation to establish precise position of EUS in treat-
ment of this disease.
Based on available diagnostic methods and capacities
of our center in treatment of primary gastric lymphoma,
the aims of this investigation are set as follows: to inves-
tigate value and significance of EUS in diagnostic of gas-
tric lymphoma, investigate value and significance of EUS
in evaluation of disease stage-staging of gastric lym-
phoma, compare pathohistological report of biopsy to
EUS finding and establish significance of EUS finding
compared to abdominal CT and ultrasound findings dur-
ing staging of the disease
Patients and Methods
of Investigation
Inclusion criteria for investigation were patients of
both genders with suspicion to gastric lymphoma. Exclu-
sion criteria are patients in whom diagnostic procedure
did not confirm gastric lymphoma, those who are due to
any cause transferred to other department and those
with incomplete medical record. Investigation was done
on 54 patients who were diagnosed with gastric lym-
phoma at the Clinic for hematology and Clinics for Gas-
troenterohepatology of the University Clinical Center of
Sarajevo in period 2002 to 2009. Total sample consisted
of 40 patients. Diagnostic team consisted of hematolo-
gist, gastroenterologist, radiologist and pathologist. Col-
lected data were analyzed and compared to pathohis-
tologically confirmed diagnosis, values of biohumoral
parameters, radiological findings of abdomen and com-
puted tomography (CT), EUS and proximal endoscopy
finding. Standard analysis of hematological parameters,
complete blood count and differential blood count, bio-
humoral parameters, protein electrophoresis and sero-
logical test to Helicobacter pylori were done (Table 1).
Radiological findings are analyzed and compared to re-
sults that determine characteristic of tissue, based on
which a suspicion is made to gastric cancer of lymphoma,
and for evaluation of diagnostic value findings are com-
pared with pathohistological finding. Results of EUS are
analyzed, i.e. evaluated for determination of stage of dis-
ease spread. A comparison to abdominal ultrasound (US)
and CT is done, and stage was determined in accordance
to the Ann Arbor classification modified by Musshoff and
Radaszkiewics. The depth of gastric wall infiltration,
structure of gastric wall and status of regional lymph
nodes was analyzed and compared to results gained via
EUS, trans-abdominal ultrasound and computerized ul-
trasound.
For pathohistological methods May Giemsa Grunwald
(MGG) staining was used. Immuno-typization included
assessment of light chains restriction, CD20, CD5, CD10,
cyclin D1, CD22, CD79a, CD30 positive or negative cells,
based on which a pathohistological type of lymphoma
was classified in accordance to WHO classification. Dif-
ferences in frequency of certain types of lymphoma, rela-
tively carcinoma between patients with suspicion to can-
cer and patients with suspicion to gastric lymphoma are
investigated via Chi-square test (c2) and Fisher exact test
(in a case that frequencies were equal or lower than 5).
Link of clinical and biochemical parameters with cancer,
relatively lymphoma, is determined with one-direction
analysis of variance (ANOVA) and Student t test for data
that followed normal distribution, relatively with Krus-
kal-Wallis and Mann-Whitney test for data that were not
normally distributed. Program SPSS Statistics 17.0 was
used for statistical analysis. P-values of <0.05 were con-
sidered statistically significant.
Results
Study included 40 patients, 21 men (52.5%) and 19
women (47.5%). Age ranged from 31 to 78 years at the
time of diagnosis. Out of total number of patients, histo-
logical analysis of gastric tumor tissue showed that 39
patients suffer from non-Hodgkin lymphoma and one pa-
tient had Hodgkin lymphoma. Out of 39 patients with
Hodgkin lymphoma, there were 6 different subtypes,
with diffuse large cell B lymphoma (DLBCL) in 17 pa-
tients, MALT lymphoma 15 patients, follicular non-
-Hodgkin lymphoma grade I 2 patients, anaplastic vari-
ant of diffuse large cell B lymphoma 1 patient, marginal
zone lymphoma 3 patients and Burkitt lymphoma 1 pa-
tient. Out of total number of patients in first stage of the
disease, there were 35 %, while in stages II, III and IV
were total of 65% patients, i.e. II stage 25%, III stage 25%
and IV stage 15%. Stage was determined by modified
Ann Arbor classification, and based on findings obtained
via EUS, CT, ultrasound of abdomen, pathohistological
finding and biohumoral parameters. Based on positive
value of IgM immunoglobulin in serological finding, 21
out of 40 patients with gastric lymphoma, had infection.
Data show that out of 21 patients with confirmed infec-
tion with Helicobacter pylori, 13 had MALT lymphoma, 6
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diffuse large cell B lymphoma and 2 other type of lym-
phoma. Out of 19 patients who did not have Helicobacter
pylori infection, 4 had MALT lymphoma i.e. 21%, 9 dif-
fuse large cell B lymphoma i.e. 47%, and 6 other types of
lymphoma 32%.
Based on EUS finding in 40 patients with malignant
gastric disease, a suspicion to gastric cancer was made in
16 patients (40%), and in 24 patients (60%) it was sus-
pected to gastric lymphoma. These working diagnosis are
made based on morphological characteristic of gastric tu-
mor visualized with endoscopic ultrasound.
Comparing three diagnostic methods, we established
that thickening of gastric mucosa > 10 mm is better de-
tected by EUS compared to CT and ultrasound UZ with
statistical significance (35 EUS vs. 18 CT p<0.001, 18
EUS vs. 10 UZ p<0.001). CT and ultrasound did not sta-
tistically differ in establishing of mucosal thickening
>100 mm (p>0.252). (Figure 1)
We did not prove advantages of one of three compared
methods for visualization in detection of enlargement of
regional lymph nodes > 10 mm (Figure 2), nor the dis-
play of enlarged retroperitoneal lymph nodes > 10 mm
(Figure 3).
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TABLE 1
BIOHUMORAL MARKERS IN PATIENTS WITH SUSPECTED GASTRIC CANCER/LIMPHOMA ACCORDING TO EUS
Laboratory
examinations
Patients divided according to
suspicion on lymphoma and







LDH U/L Probably cancer 24 412.75 55.145
Probably lymphoma 16 862.12 465.558
Sedimentation ratio 0 sek Probably cancer 23 36.48 5.764
Probably lymphoma 16 33.31 7.143
Leucocytes 109/L Probably cancer 24 8.4592 0.93185
Probably lymphoma 16 6.5012 0.44205
Haemoglobin g/L Probably cancer 24 117.12 2.800
Probably lymphoma 16 103.88 4.237*
Fe in blood mg/L Probably cancer 24 6.881 1.1118
Probably lymphoma 16 9.606 1.8642
Beta 2microglobulin Probably cancer 24 3.2375 0.39722
Probably lymphoma 16 3.6844 0.45175
Total proteins g/L Probably cancer 24 69.58 1.359
Probably lymphoma 16 66.81 2.197
Albumins g/L Probably carcinoma 24 35.04 1.140
Probably lymphoma 16 34.94 1.537
Globulins g/L Probably carcinoma 24 34.04 1.021
Probably lymphoma 16 31.88 1.581
alfa1globulins g/L Probably carcinoma 24 0.0404 0.00237
Probably lymphoma 16 0.0381 0.00306
alfa2globulins g/L Probably carcinoma 24 0.1129 0.00591
Probably lymphoma 16 0.1100 0.00791
beta2globulins g/L Probably carcinoma 24 0.1375 0.00302
Probably lymphoma 16 0.1338 0.00499
Gama globulins g/L Probably carcinoma 24 0.2104 0.00854
Probably lymphoma 16 0.2100 0.01671
Fig. 1. Infiltration of gastric wall.
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Discussion
Gastric lymphoma is relatively rare condition. Based
on pathohistological type, the most common type is MALT
lymphoma, followed by diffuse large B cell lymphoma
and other types of B cell lymphoma in less number of
cases. Out of 40 patients with gastric lymphoma, in-
cluded in our study, 39 of them had various types of
non-Hodgkin lymphoma, 17 patients with diffuse large B
cell lymphoma, 15 patients with MALT lymphoma, 2 pa-
tients with follicular lymphoma grade I, 1 patient with
diffuse large B cell lymphoma-anaplastic variant, 3 pa-
tients with marginal zone lymphoma and 1 patient with
Burkitt lymphoma and only one with Hodgkin lympho-
ma. Out of total number, 48% of patients were infected
with Helicobacter pylori. In our investigation, in a group
of patients with gastric lymphoma, female patients rep-
resented 48% of the sample, while male patients repre-
sented 52% of the sample. Average age of the patients
was 54.5. These data are completely contrary to the data
from other, similar investigations9. Prognosis and treat-
ment of primary gastric lymphoma depends of patho-
histological diagnosis and stage of the disease10.
A combination of proximal endoscopy, CT and abdom-
inal ultrasound was used for staging of the disease in the
past. Due to technically limited abilities of used instru-
ments, results had poor accuracy (34). New abilities of
precise detection and staging of the disease are being in-
vestigated in order to start with appropriate therapeutic
procedures on time. Appearance of endoscopic ultra-
sound is followed by numerous studies, which try to de-
termine importance of EUS in diagnostics and staging of
gastric lymphoma, especially of MALT subtype. There is
a great deal of evidences today which speak in favor of
the fact that EUS significantly improved precise staging
of gastric lymphoma11. In that manner, Jensen quotes
that EUS is essential in diagnosis of primary gastric
lymphoma10. Ruskoe-Formestreaux established that EUS
in diagnostic of gastric lymphoma in better in visualiza-
tion of lymphoma infiltrate than conventional methods
like abdominal ultrasound and computerized tomogra-
phy12.
Results of our investigation show that stage of the
disease and depth of infiltration of the gastric wall as-
sessed by the EUS were significantly more precise com-
pared to computerized tomography and ultrasound of ab-
domen what is in accordance with results of above quo-
ted authors. EUS detected the gastric wall infiltration in
35 patients while CT reported it in 18 patients, and with
abdominal ultrasound in 13 patients. Endoscopic ultra-
sound did not report infiltration in 5 patients, while CT
did not evident infiltration in 22, and abdominal ultra-
sound in 27 patients.
Nakamura et al. showed detailed evaluation of depth
of infiltration of MALT lymphoma in gastric submucosa
based on EUS finding and therefore concluded that the
stage determined by EUS is more superior that stage de-
termined by the Ann Arbor classification since prognosis
of therapy response was more precise13. These results
show that evaluation of depth of infiltration of first two
layers of gastric wall is more important than evaluation
of regional lymph nodes involvement. Similar results
were obtained by Levy et al. who proved that EUS can
differentiate superficial from infiltrative type of MALT
lymphoma of gastric mucosa14.
In the procedure of staging for gastric lymphoma it is
essential to evaluate radiologically involvement of peri-
gastric lymph nodes. Zinzanni quotes that EUS is more
sensitive method in detection of infiltrated lymph nodes
compared to abdominal CT8. It is interesting that Zucca,
in his results, links depth of gastric mucosa infiltration
with lymphoma to its dissemination to perigastric lymph
nodes. His quotes are in correlation with our results
where we proved applicability of EUS in assessment of
depth of gastric wall infiltration. Unfortunately, we did
not confirm superiority of EUS compared to CT when de-
cide involvement of perigastric lymph nodes that would
confirm results of Zinzanni et al. in our results. Large
number of studies analyzed role of EUS in treatment of
gastric lymphoma and conclusions are contradictory.
Gastric lymphoma is a separate entity since there is
no general consensus on classification system for staging
of the disease. Three classifications are currently used
for staging gastric lymphoma. These are modified Ann
Arbor system, Lugano Staging system for gastrointesti-
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Fig. 2. Regional lymph node involvement established by respec-
tive diagnostic method.
Fig. 3. Enlargement of retroperitoneal lymph nodes diagnosed by
respective method.
U:\coll-antropolo\coll-antro-(Suppl 1)-2013\Vanis.vp
3. travanj 2013 11:56:18
Color profile: Generic CMYK printer profile
Composite  150 lpi at 45 degrees
nal lymphoma and TNM staging system. According to
Zucca it is questionable which system is the best to do
staging14,15. Zucca used Lugano staging system.
Calletti et al. recommend TNM system of staging for
solitary tumor since the prognosis is analogue to progno-
sis of gastric cancer compared to stage. Same authors
recommend use of EUS in evaluation of depth of gastric
wall infiltration since it is in correlation with treatment
outcome11. In our study we used modified Ann Arbor sys-
tem with which we discovered that 65% patients were in
clinical stages II, III and IV, while 35% of them were in
clinical stage I. Raderer et al. obtained similar results in
analysis of newly discovered MALT lymphoma using
modified Ann Arbor system and evidenced percentage in-
volvement of advanced clinical stage 43%. Compatibility
of these data can be explained with the fact that both
studies used method, modified Ann Arbor system in diag-
nostic procedure. Large number of published studies
used different systems to stage the gastric lymphoma.
Their results cannot adequately be compared. Multi-
-centric studies with large sample and use of uniform
system for staging of the disease are needed to expect
more precise and convenient data.
According to Janssen, MALT lymphomas make larg-
est part of primary gastric lymphomas which develop
during chronic infection with Helicobacter pylori10. We
found same conclusions in paper of Hancock et al who
found prevalence of Helicobacter pylori infection in pa-
tients with MALT lymphoma higher than 90 % 16. Agency
for investigation of cancers in 1994, based on different
investigation results, listed Helicobacter pylori into first
class of carcinogens, relatively triggers in process of gas-
tric carcinogenesis17.
When it comes to gastric lymphoma there is no con-
sensus on role of Helicobacter pylori in their ethiopatho-
genesis. Even though MALT lymphoma is not extremely
rare, it accounts to 7.6% of 1 378 non Hodgkin lymphoma
in international study for evaluation of importance of
REAL classification. The highest incidence of gastric
MALT lymphoma was recorded in northern Italy, 13.2 to
100 000 people a year, 13 times higher than in appropri-
ate communities in Great Britain. This suggests that
there is a significant variability in geographic distribu-
tion. It was speculated that uncommon high incidence of
primary gastric lymphoma is connected to extremely
high percent of Helicobacter pylori infection in investi-
gated population. In the United States incidence is evalu-
ated between 1:30 000 and 1:80 000 in population with
Helicobacter pylori infection. However, additional un-
known hereditary factors or nutritional habits can also
have significant role. In some cases of primary gastric
lymphoma Helicobacter pylori infection is not detected
at all15.
Hussel et al. in their investigation claim that growth
of MALT lymphoma depends on antigen stimulation of
gastric mucosa by Helicobacter pylori18.
Despite numerous studies which link appearance of
MALT and presence of Helicobacter pylori19–22), there are
data of certain percent of MALT lymphoma infected with
Helicobacter pylori which do not respond to eradication
therapy of Helicobacter pylori8,13,23, and that its connec-
tion with onset of MALT still does not have enough scien-
tific proofs. Montalban in his study states that Heli-
cobacter pylori infection cause MALT in a form of
follicular gastritis and that its infection is present in
most of indolent gastric MALT lymphoma. Now is known
that MALT lymphoma, which are not associated with
Helicobacter pylori infection, do not respond well to
eradication antibiotic treatment. In certain number of
these cases it clearly depends on probably present but
not detected component of high grade malignant
lymphoma22. Recent investigations from year 2010 on
pathogenesis of MALT lymphoma draw special attention.
They are based on inclusion of genetic aberration of
oncogenic pathway of nuclear factor B (English nuclear
factor kappa B – NF kappa B), which is the best investi-
gated route in immunology and oncogenesis. It is quoted
that gastric MALT lymphoma is extraordinary example
of close tie between chronic inflammation and tumor de-
velopment. It is described that gastric MALT lymphoma
is one of the best models how genetic disorders lead to
oncogenesis, determine biology of tumor, dictate its clini-
cal behavior and present potential therapy target24.
Calletti et al points out that most likely Helicobacter
pylori has a role in transformation of MALT to diffuse
large B cell lymphoma, with note that all listed lym-
phoma do not develop form existing MALT in presence of
Helicobacter pylori11. Other study established large cor-
relation between presence of Helicobacter pylori and gas-
tric lymphoma25.
While investigating presence of Helicobacter pylori
via serological test we established that it was positive in
52.5% patients. Out of that number 61.1% were MALT
lymphoma, 28.5% diffuse large cell B lymphoma and
9.5% other types of lymphoma. Our data suggest that
Helicobacter pilory is possible etiological factor in onset
of gastric lymphoma, firstly MALT type of lymphoma.
Less number of patients with DLBCL was Helicobacter
pylori positive and the association with its onset is still
questionable. However relation of MALT and diffuse
large B cell lymphoma and the role of Helicobacter pylori
infection remain controversial. Previous studies demon-
strated significant percent of complete remission of
DLBCL following eradication therapy for Helicobacter
pylori in patients who had concomitant MALT lympho-
ma20. These data suggest that bacteria Helicobacter py-
lori is in certain percent linked to progression to DLBCL.
Nakamura et al. established that only 50% of gastric
MALT lymphoma is of high risk in clinical stage I with
infiltration of mucosa found on EUS responded favorably
to eradication therapy for Helicobacter pylori26.
Large number of studies is dealing with issue of pri-
mary gastric lymphoma and infection with Helicobacter
pylori. It is necessary to point out to the fact that there is
a certain number of patients who do not have infection
with Helicobacter pylori, and have primary gastric lym-
phoma. In our study we found that out of total number of
patients 52% were negative to Helicobacter pylori infec-
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tion. Out of total number of Helicobacter pylori negative
patients, 47% were patients with DLBCL lymphoma,
while 21 % of them were with MALT lymphoma. Signifi-
cantly higher number of DLBCL patients is Helicobacter
pylori negative compared to MALT lymphoma Helico-
bacter pylori negative patients. Our results are in favor
of investigations which do not connect DLBCL with
Helicobacter pylori infection25.
In a study by Zucca et al. small number of patients
with MALT lymphoma has clinical B symptoms. In some
patients values of lactate dehydrogenase and beta 2 mi-
croglobulin were not elevated27, what is in correlation
with our results. The presence of B symptoms which
would be statistically significance is not established. We
did not established elevated values of LDH and beta2
microglobulin in this group of patients. According to in-
vestigation of Lepicard in most patients with B symp-
toms difficulties are linked to disturbance in upper gas-
trointestinal tract. That group of patients did not have
elevated values of LDH and beta2 microglobulin, what
confirms result of our investigation15,28. Two listed labo-
ratory parameters are one of prognostic markers for ag-
gressive and indolent lymphoma29. Beta2 microglobulin
together with LDH, is important prognostic parameter of
therapeutical response and survival, and both are in-
cluded into IPI prognostic index. Elevated values of both
parameters demonstrate very fast relapse of the disease
and only one third of patients lives longer than two
years.
Results of our investigation showed that anemia was
more expressed in group of patients with MALT lym-
phoma compared to group of patients with diffuse large
B lymphoma, where there was statistically significant
difference. Zucca et al. quote microcytic sideropenic ane-
mia, in some cases only microcytosis without anemia and
lack of iron15 what correlates with findings of our investi-
gation. Differences in hemoglobin values may be con-
nected with indolent nature of MALT lymphoma, be-
cause the disease last longer to onset of all symptoms.
Due to slow progression of the disease, appearance of oc-
cult hemorrhage lasting for long time is possible. Other
cause of anemia is chronic anemia. It is specific due to
characteristic in iron metabolism, where repeated utili-
zation of iron from tissue to serum is blocked, firstly by
monocyte-macrophage system. Appearance of subclinical
form of hemolysis, due to shorter lifetime of erythrocytes
and relative insufficiency of bone marrow, is also possi-
ble. It is usually caused by the inhibition of erythrocytes
production in adequate number, necessary to compen-
sate its enhanced destruction. Lowered values of serum
iron were maybe caused by the reduced absorption due to
loss of appetite46. Unlike MALT, diffuse large cell B lym-
phoma is aggressive lymphoma and constitutional symp-
toms appear earlier what might affects earlier diagnos-
ing and in shorter period do not develop anemia of
chronic disease or the occult bleeding last long.
In literature there are no data on controversial issue
if the EUS is more sensitive from proximal endoscopy
with targeted and mapped biopsies of gastric mucosa for
early diagnostics and relapse of gastric lymphoma. In our
study group of 40 patients, in whom there was a suspi-
cion to malignant gastric tumor and in whom histopa-
thology verified primary gastric lymphoma, was ana-
lyzed. EUS analyzed tumor mass in gastric mucosa,
which was described based on its radiological character-
istics and depth of its infiltration. Finding of EUS com-
pared to pathohistological finding of tissue sample from
gastric wall is in 40% cases directed that it is cancer. In
those patients EUS finding was not in correlation to
pathohistological diagnosis so it is concluded that EUS is
not sufficient in making diagnosis of gastric lymphoma.
These results are not in correlation with findings of
Capelle et al who quote that endoscopic ultrasound can
confine benign lymphoid infiltration from lymphoma with
high percent, what we did not confirm in our investiga-
tion25.
Jensen notes that EUS is not suitable for detection of
locus of lymphoma which are not detected via endosco-
py10. Diagnostics of gastric lymphoma is based to proxi-
mal endoscopy which is used to sample tissue from differ-
ent locations of gastric mucosa and pathohistological
analysis of tumor tissue samples31.
In recently published literature we had access to, it is
quoted that EUS is generally accepted as the most pre-
cise method to assess local stage of gastric lymphoma, in-
cluding detection of involved regional lymph nodes. Data
from literature are still scarce and contradictory. They
are results of studies published between 1992 and 2002
while the standard treatment for gastric lymphoma was
surgical resection. In accordance to this staging of the
disease with EUS could be compared to the results of
pathohistological findings in these studies10,31,32. At this
point prospective studies with technically improved EUS
and more experienced specialists for endoscopy, which
would resolve opposing attitudes, are not expected since
gastrectomy following pathohistological verification are
avoided33.
Outcome of primary gastric lymphoma treatment for
MALT and DLBCL treated with chemotherapy, radio-
therapy or surgical resection in I and II clinical stage, in
study by Schramm et al. was not different since there
was no difference in length of survival34. Analyzes of
quality of life established that patients with preserved
stomach had significantly better quality of life than
gastrectomy patients.
These data are important for planning treatment of
patients with primary gastric lymphoma what also shows
significance of adequate diagnostic procedure. It is clear,
from quoted discussion that optimal diagnosis and treat-
ment of MALT lymphoma, asks for integration of mor-
phological, immunohistochemical and molecular data by
pathologist in close cooperation with clinician. Diagnosis
of MALT lymphoma ask also for molecular analysis of
translocation t(11,18)(q21,21)/API2-MALTl1. Due to cli-
nical implication some authors recommend detection of
DLBCL lymphoma, which coexists with MALT lympho-
ma, and to detailed endoscopies, in order to sample tissue
for biopsies from more locations28. Above mentioned is
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necessary to confirm or exclude presence of transforma-
tion in DLBCL. Endoscopy can be supplemented with
EUS in order to obtain detailed data on stage of the dis-
ease.
Future studies should direct importance to the defin-
ing value of EUS in process of diagnostics and precise de-
termination of gastric lymphoma stage.
R E F E R E N C E S
1. YOUNG NS, GERSON SL, HUGH KA, Clinical hemathology
(Elsevier Inc., 2006). — 2. FUSAROLI P, BUSCARINI E, Gastrointest
Endosc, 55 (2002) 662. DOI: 10.1067/mge.2002.123421. — 3. RADERER
M, STREUBEL B, WOEHRER S, PUESPOEK A, JAEGER U, FORMA-
NEK M, CHOTT A, Clin Cancer Res, 11 (2005) 3349. DOI: 10.1158/1078-
0432.CCR-04-2282. — 4. PÜSPÖK A, RADERER M, CHOTT A, DRA-
GOSICS B, GANGL A, SCHÖFL R, Gut, 51 (2002) 691. DOI: 10.1136/
gut.51.5.691. — 5. SWERDLOW S, Classification of Tumors of Haema-
topoetic and Lymphoid Tissues, 4th edition(IARC Lyon, 2008). — 6.
ISAACSON PG, SPENCER J, Histopathology, 11 (1987) 445. DOI: 10.
1111/j.1365-2559.1987.tb02654.x. — 7. RADER M, WOHRER S, STREU-
BEL B, TROCH M, TURETSCHEK K, J Clin Oncol, 24 (2006). — 8. ZIN-
ZANI PL, Leuk Lymphoma, 47 (2006) 2013. DOI: 10.1080/10428190600
774873. — 9. HOEPFFNER N, LAHME T, GILLY J, MENZEL J, KOCH P,
FOERSTER EC, Med Klin (Munich), 98 (2003) 313. DOI: 10.1007/
s00063-003-1263-z. — 10. JANSSEN J, Best Pract Res Clin Gastroen-
terol. 23 (2009) 671. DOI: 10.1016/j.bpg.2009.05.008. — 11. CALETTI G,
ZINZANI PL, FUSAROLI P, BUSCARINI E, Aliment Pharmacol Ther, 16
(2002) 1715. — 12. RUSKONÉ-FOURMESTRAUX A, FISCHBACH W,
ALEMAN BM, BOOT H, Gut, 60 (2011) 747. DOI: 10.1136/gut.2010.
224949. — 13. NAKAMURA S, MATSUMOTO T, SUEKANE H, TAKE-
SHITA M, Gut, 48 (2001) 454. — 14. LÉVY M, HAMMEL P, LAMARQUE
D, MARTY O, Gastrointest Endosc, 46 (1997) 328. — 15. ZUCCA E,
DREYLING M, ESMO Guidelines Working Group, Ann Oncol, Suppl 4
(2009) 113. DOI: 10.1093/annonc/mdp146. — 16. Hancock BW, Qian W,
Linch D, Delchier JC, Br J Haematol, 144 (2009) 367. DOI: 10.1111/j.
1365-2141.2008.07486.x. — 17. YEH HZ, CHEN GH, CHANG WD,
POON SK, J Gastroenterol Hepatol, 18 (2003) 162. — 18. HUSSELL T,
ISAACSON PG, CRABTREE JE, SPENCER J, Lancet, 342 (1993) 571.
DOI: 10.1016/0140-6736(93)91408-E. — 19. PAVLICK AC, GERDES H,
PORTLOCK CS, J Clin Oncol, 15 (1997) 1761. — 20. MORGNER A, MIE-
HLKE S, STOLTE M, NEUBAUER A, World J Gastroenterol, 7 (2001)
248. — 21. FARINHA P, GASCOYNE RD, Gastroenterology, 128 (2005)
1579. DOI: 10.1053/j.gastro.2005.03.083. — 22. MONTALBAN C, SAN-
TON A, BOIXEDA D, REDONDO C, Haematologica, 86 (2001) 609. —
23. RUSKONÉ-FOURMESTRAUX A, LAVERGNE A, AEGERTER PH,
MEGRAUD F, Gut, 48 (2001) 297. DOI: 10.1136/gut.48.3.297. — 24. SA-
GAERT X, VAN CUTSEM E, DE HERTOGH G, GEBOES K, Nat Rev
Gastroenterol Hepatol, 7 (2010) 336. DOI: 10.1038/nrgastro.2010.58. —
25. CAPELLE LG, DEN HOED CM, DE VRIES AC, BIERMANN K, Eur
J Gastroenterol Hepatol, 24 (2012) 42. DOI: 10.1097/MEG.0b013e32834d
85e6. — 26. TSANG RW, GOSPODAROWICZ MK, PINTILIE M, WELLS
W, J Clin Oncol, 21 (2003) 4157. DOI: 10.1200/JCO.2003.06.085. — 27.
ZUCCA E, BERTONI F, ROGGERO E, CAVALLI F, Blood, 96 (2000) 410.
— 28. BACON CM, DU MQ, DOGAN A, J Clin Pathol, 60 (2007) 361.
DOI: 10.1136/jcp.2005.031146. — 29. LABAR B, HAUPTMAN E, Hema-
tologija, ([kolska knjiga, Zagreb, 1998). — 30. MILO[EVI] R, TODO-
ROVI] M, BALINT B, SMILJANI] M, Acta Clinica, 10 (2010) 97. — 31.
PSYRRI A, PAPAGEORGIOU S, ECONOMOPOULOS T, Ann Oncol, 19
(2008) 19929. DOI: 10.1093/annonc/mdn525. — 32. FUJISHIMA H, MI-
SAWA T, MARUOKA A, CHIJIIWA Y, Am J Gastroenterol, 86 (1991) 719.
— 33. PALAZZO L, ROSEAU G, RUSKONE-FOURMESTRAUX A, ROU-
GIER P, Endoscopy, 25 (1993) 502. DOI: 10.1055/s-2007-1010385. — 34.
FISCHBACH W, SCHRAMM S, GOEBELER E, Z Gastroenterol, 49
(2011) 430. DOI: 10.1055/s-0029-1246012.
R. Dobrila-Dintinjana
University of Rijeka, Rijeka University Hospital Center, Department of Radiotherapy and Oncology,
Kre{imirova 42, Rijeka, Croatia
e-mail: renatadobrila@windowslive.com
PREDIKTIVNA VRIJEDNOST ENDOSKOPSKOG ULTRAZVUKA U DIJAGNOSTICI
I STAGINGU PRIMARNOG LIMFOMA @ELUCA
S A @ E T A K
Cilj rada je bio istra`iti zna~aj endoskopskog ultrazvuka u dijagnostici i utvr|ivanju stadija bolesti u limfoma `eluca.
Proveli smo retrospektivnu klini~ku studiju na Klinici za hematologiju i Klinici za gastroenterologiju Klini~kog bol-
ni~kog centra Sarajevo u razdoblju od osam godina. Uklju~eni su bolesnici (N=40) s patohistolo{ki potvr|enom dijagno-
zom limfoma `eluca. Stadij bolesti se odre|ivao na temelju nalaza EUS-a, endoskopije gornjeg dijela probavnog sustava,
kompjuterizirane tomografije i abdominalnog ultrazvuka, a klasifikacija se vr{ila prema Ann Arbor sustavu. Samo
jedan bolesnik je imao Hodgkin limfom, a 39 njih su imali ne-Hodgkin limfom. Prema morfolo{kim karakteristima
vizualiziranim s EUS-om, u 16 bolesnika bila je postavljena sumnja na karcinom `eluca. U 40% bolesnika nalaz na
EUS-u nije potvr|en i patohistolo{ki. U usporedbi s kompjuteriziranom tomografijom i abdominalnim ultrazvukom,
EUS je pokazao statisti~ki signifikantno vi{u u~estalost otkrivanja infiltracije tkiva (p<0,001). U bolesnika s primar-
nim limfomom `eluca, EUS ima zna~ajniju ulogu u utvr|ivanju stupnja {irenja bolesti nego postavljanja same dijag-
noze. Stoga bi EUS trebalo uklju~iti u algoritam dijagnosti~kih pretraga bolesnika kada se sumnja na malignu bolest
`eluca.
N. Vanis et al.: Ultrasound in Diagnosis and Staging of Primary Gastric Lymphoma, Coll. Antropol. 37 (2013) Suppl. 1: 291–297
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